Regeneron hopes for full FDA approval of COVID-19 antibody cocktail
The treatment currently has emergency use authorization.
•
Oct 14, 2021, 4:54 PM
•
Updated 1,087 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
27ds ago
Hometown Heroes in the Hudson Valley
74ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
218ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
239ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
366ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
366ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
27ds agoHometown Heroes in the Hudson Valley
74ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
218ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
239ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
366ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
366ds agoA new medicine to treat COVID-19 could be on the way as the Food and Drug Administration has started its review of 's COVID-19 antibody cocktail.
The Tarrytown-based biotech company says the FDA accepted its priority review application and they are hoping to receive full approval
The treatment currently has emergency use authorization.
Regeneron wants full approval to treat patients infected with the virus who are not in the hospital.
More from News 12
2:07
Sunny and pleasant Sunday in the Hudson Valley; rain chance into Monday
1:28
Museum: Old Rhinebeck Aerodrome board member killed in air show crash
1:53
Operation Bundle Up gives over 1,000 winter coats to children in White Plains
2:17
Study: More women under 50 are being diagnosed with breast cancer
0:26
State police: Somers man posing as lawyer online convinced victim to pay $7,500
0:29
